Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – “There is no strong evidence” that any significant subpopulation of breast cancer patients diagnosed in the 1980s and early 1990s was ever “cured,”…
NEW YORK (Reuters Health) – Environmental exposure to tobacco smoke – a known risk factor for myocardial infarction and other acute coronary syndromes (ACS) – can also worsen…
NEW YORK (Reuters Health) – Stroke is uncommon after percutaneous coronary intervention (PCI), according to a study of the American College of Cardiology National Cardiovascular Data Registry (NCDR).…
NEW YORK (Reuters Health) – Patients with high-risk esophageal varices treated with the beta-blocker carvedilol had lower rates of first bleeding episodes than patients treated with variceal band…
NEW YORK (Reuters Health) – Neoadjuvant hormonal therapy for prostate cancer may increase the risk of death in men with coronary artery disease-induced heart failure or myocardial infarction…
Jay Alberts, PhD, Assistant Staff, Lerner Research Institute, Cleveland Clinic, gives us an overview of Parkinson’s Disease and describes study results which showed that exercise therapy had a…
Jay Alberts, PhD, Assistant Staff, Lerner Research Institute, Cleveland Clinic, discusses research findings on forced exercise for patients with Parkinson’s Disease. Summary 1. Based on research findings, Parkinson’s…
The diagnosis of prostate cancer can be a confusing and scary time for many men. Ken Burger discusses his process of learning to adapt and deal with the…
NEW YORK (Reuters Health) – Laparoscopic surgery is as efficient as open surgery for rectal cancer, according to results of a randomized trial. Dr. Juan Lujan and colleagues…
NEW YORK (Reuters Health) – Long-term, high-dose ursodeoxycholic acid (UDCA) should not be used for treatment of primary sclerosing cholangitis because of the increased risk of severe adverse…
